MedTrace Logo

Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy

NCT06297083 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will compare the effectiveness of three different treatments to treat peanut allergy

Conditions

Interventions

DRUG

Peanut Oral Powder [PEANUT POWDER]

Peanut oral immunotherapy at varying doses and build-up regimes given daily for 18 months

DIETARY_SUPPLEMENT

Probiotic (LGG®, Lactobacillus Rhamnosus) or placebo probiotic (maltodextrin)

Probiotic or placebo-probiotic given daily for 18 months

Sponsors & Collaborators

  • Murdoch Childrens Research Institute

    lead OTHER

Principal Investigators

  • Paxton Loke · Murdoch Childrens Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2027-05-31
Completion
2027-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06297083 on ClinicalTrials.gov